Key result
The role of radiotherapy in the treatment of Hodgkin's lymphoma is decreasing, with extended field irradiation in early stages being replaced by short periods of chemotherapy followed by limited radiotherapy to decrease late sequelae.
Why the study?
Does radiation therapy improve survival and what are its long-term effects in patients with Hodgkin's lymphoma?
Population
27,280 patients with Hodgkin's lymphoma from 58 scientific articles.
Comparison
Radiation therapy vs Chemotherapy alone, or different radiation…
Design
Systematic_review
Follow-up
up to 15-20 years
Authors
Loading...
Supports de-escalation of radiotherapy fields in Hodgkin lymphoma to reduce late cardiovascular and malignancy risks; confirms 1996 overview findings.
Systematic Review (n=27,280)
Does radiation therapy improve survival and what are its long-term effects in patients with Hodgkin's lymphoma?
Long-term follow-up of Hodgkin's lymphoma patients reveals that treatment-related mortality, particularly cardiovascular disease and secondary cancers, exceeds disease-specific mortality after 15-20 years, prompting a reduction in radiotherapy use.
Gustavsson et al. (2003) conducted a systematic review in Hodgkin's lymphoma (n=27,280). Radiotherapy vs. Chemotherapy or reduced radiotherapy was evaluated. The role of radiotherapy in the treatment of Hodgkin's lymphoma is decreasing, with extended field irradiation in early stages being replaced by short periods of chemotherapy followed by limited radiotherapy to decrease late sequelae.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: